TheProfitWatch

KURA - Kura Oncology, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.87 0.47 (4.76%) --- --- 0.0 (0.0%) 0.0 (0.0%) 0.59 (6.08%) 0.04 (0.39%) 0.04 (0.39%)

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.75
Diluted EPS:
-0.75
Basic P/E:
-13.7867
Diluted P/E:
-13.7867
RSI(14) 1m:
100.0
VWAP:
10.34
RVol:
1.3619

Events

Period Kind Movement Occurred At
1m Price decrease 1m 10.07 -0.12 (-1.18%) Oct 15 12:05

Related News